Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
Hans-Olov AdamiIna Trolle AndersenUffe Heide-JørgensenEllen T ChangMette NørgaardHenrik Toft SørensenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Our results, which do not support any carcinogenic effect on esophagus, stomach, liver or pancreas, should be reassuring for millions of concerned past users of ranitidine.
Keyphrases